Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03111173
Other study ID # STUDY00001556
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 2, 2017
Est. completion date December 2026

Study information

Verified date January 2024
Source University of Washington
Contact Martin G Frasch, MD, PhD
Phone 206-543-5892
Email mfrasch@uw.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a feasibility study for a new application for capturing fetal cardiac activity. The objective of this study is to determine if it is feasible to capture a fetal ECG signal using a Holter ECG device. As comparison we will use a standard Doppler Fetal Heart Rate (FHR) device.


Description:

The objective of this study is to determine if it is feasible to capture a fetal ECG signal using a Holter ECG device. As comparison we will use a standard Doppler Fetal Heart Rate (FHR) device. To obtain the raw FHR data from this standard device we will use the currently approved "fetal EEG" monitor. The important distinction is that "fetal EEG" monitor will not be connected to fetal scalp electrode, but, rather, get the data from the regular, more routinely used and non-invasive Doppler FHR monitor. We expect that we will be able to validate our algorithm with our maternal and fetal ECG channels to derive the FHR. We will attach a Holter ECG device (4 electrodes) and a standard Doppler FHR device to a pregnant woman who is between 32 weeks gestation and full term. ECG leads will be placed in four corners of the abdomen. The targeted length of the recording will be 30 minutes. The subject will remain supine and resting while the device is recording. Additionally, the recently approved fetal EEG monitor will be connected to the Doppler FHR device to allow us to obtain a "digital copy" of the standard FHR recording. We will do that in order to have the comparison during the offline processing of the abdominal ECG with regard to the location of the fetal R peaks. This procedure will be done after the subject's routine antepartum testing. No women in active labor will be recruited.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 2026
Est. primary completion date June 2025
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - Singleton or twin pregnant women at 32 weeks gestation to full term after routine antepartum testing. Exclusion Criteria: - None.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Holter Device
MyECG E3.80 Holter Recorder

Locations

Country Name City State
United States University of Washington Seattle Washington

Sponsors (2)

Lead Sponsor Collaborator
University of Washington Duke University

Country where clinical trial is conducted

United States, 

References & Publications (1)

Efficient fetal-maternal ECG signal separation from two channel maternal abdominal ECG via diffusion-based channel selection Ruilin Li, Martin G. Frasch, Hau-tieng Wu (Submitted on 7 Feb 2017) There is a need for affordable, widely deployable maternal-fetal ECG monitors to improve maternal and fetal health during pregnancy and delivery. Based on the diffusion-based channel selection, here we present the mathematical formalism and clinical validation of an algorithm capable of accurate separation of maternal and fetal ECG from a two channel signal acquired over maternal abdomen. Subjects: Medical Physics (physics.med-ph); Data Analysis, Statistics and Probability (physics.data-an); Applications (stat.AP); Machine Learning (stat.ML) Cite as: arXiv:1702.02025 [physics.med-ph]

Outcome

Type Measure Description Time frame Safety issue
Primary Successful extraction of fetal ECG from the maternal abdominal ECG signal We will test the quality of correct identification of fetal R peaks of ECG from within maternal ECG signal by comparing the R-R-periods-derived instantaneous fetal heart rate (FHR) to the values determined by the standard-of-care ultrasound-derived FHR monitor. 12 months
See also
  Status Clinical Trial Phase
Completed NCT03244865 - Refinement of the OBMedical LaborView System
Not yet recruiting NCT05933928 - The Effect of Simulation-based Electronic Fetal Monitoring Training on Midwifery Students N/A
Completed NCT04779294 - The Oslo Stan vs Lactate Observational Study
Recruiting NCT05938790 - Point of Care Ultrasound in Obstetric Triage N/A
Not yet recruiting NCT05510349 - Prevention of Per-partum Fetal Hypoxia: Measure of Placental Elasticity and Viscosity During Labor N/A
Terminated NCT02950896 - Intraoperative Fetal Heart Rate (FHR) Monitoring: a Feasibility Study
Not yet recruiting NCT03268486 - Evaluation of a Novel Signal Acquisition Technique for Intrapartum Cardiotocography N/A
Recruiting NCT06135961 - Intrapartum Non-invasive Electrophysiological Monitoring N/A
Recruiting NCT05847790 - Remote Pregnancy Monitoring to Improve Access N/A
Completed NCT02790554 - Moyo; strap-on Fetal Heart Rate Monitoring in an Urban Setting N/A
Completed NCT05060172 - A Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Antepartum Fetal Monitoring N/A
Recruiting NCT05665400 - A Clinical Study for the Development of a Device (Lovelace) for Antepartum Fetal Monitoring N/A
Completed NCT02790814 - Moyo; strap-on Fetal Heart Rate Monitoring in a Rural Setting N/A
Completed NCT05863156 - Evaluation of the Effects of Different Positions Given During Antenatal Electro-Fetal Monitoring N/A
Completed NCT04915131 - A Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Performing Antepartum Fetal Monitoring N/A
Not yet recruiting NCT06355453 - Evaluation of the Goldcrest Patch Performance